Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

n/a
Abstract Title:

Tumor Necrosis Factor alpha (TNF-α) reduces intestinal vitamin C uptake: a role for NF-κB mediated signaling.

Abstract Source:

Am J Physiol Gastrointest Liver Physiol. 2018 Apr 6. Epub 2018 Apr 6. PMID: 29631379

Abstract Author(s):

Veedamali S Subramanian, Subrata Sabui, Ganapathy A Subramenium, Jonathan S Marchant, Hamid M Said

Article Affiliation:

Veedamali S Subramanian

Abstract:

Sodium-dependent vitamin C transporter-1 (SVCT-1) is the major transporter mediating intestinal vitamin C uptake. Intestinal inflammation and prolonged infection are associated with an increased serum and intestinal mucosa levels of TNF-α, which also exerts profound effects on intestinal absorption process. Elevated levels of TNF-α have been linked to the pathogenesis of IBD and malabsorption of nutrients and these patients have low levels of vitamin C. To date, little is known about the effect of TNF-α on intestinal absorptionof vitamin C. We studied the impact of TNF-α on ascorbic acid (AA) transport using variety of intestinal preparations. The expression level of hSVCT-1 mRNA is significantly lower in IBD patients. TNF-α treated Caco-2 cells and mice showed a significant inhibition of intestinalC-AA uptake. This inhibition was associated with significant decreases in SVCT-1 protein, mRNA and hnRNA levels in TNF-α treated Caco-2 cells, mouse jejunum, and enteroids. Also, TNF-α caused a significant inhibition in the SLC23A1 promoter activity. Furthermore, treatment of Caco-2 cells with celastrol (NF-κB inhibitor) blocked the inhibitory effect caused by TNF-α on AA uptake, SVCT-1 protein and mRNA expression, as well as the activity of SLC23A1 promoter. Treatment of TNF-α also led to a significant decrease in the expression of HNF1α, which drives the basal activity of SLC23A1 promoter and this effect was reversed by celastrol. Together, these findings show that TNF-α inhibits intestinal AA uptakeand this effect is mediated, at least in part, at the level of transcription of the SLC23A1 gene via the NF-κB pathway.

Study Type : In Vitro Study

Print Options


Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2019 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.